(Total Views: 598)
Posted On: 04/01/2022 4:27:36 PM
Post# of 22467
Re: simpleknight #21472
Briefly, QD based multivariate tests are the next-gen Covid tests, and possible, as are special tests for BTI and cancers, etc.
QMC biz model is license and royalties and display industry demands lowest commodity price so I doubt QMC will play that losing game. Proof is that Nanosys has never IPO'd as the low price QD leader.
A company needs a war chest to sue to defend patents. it's a double edged sword.
QMC is international doing business overseas, maybe to make itself less dependent on the FDA, similar to how Innova did billions in business. Pharma companies are worldwide and serve specific markets. While the US is a big one, it's not the only one.
This and all my posts are my opinion and speculation on possible scenarios and not investment advice. Do your own due diligence.
QMC biz model is license and royalties and display industry demands lowest commodity price so I doubt QMC will play that losing game. Proof is that Nanosys has never IPO'd as the low price QD leader.
A company needs a war chest to sue to defend patents. it's a double edged sword.
QMC is international doing business overseas, maybe to make itself less dependent on the FDA, similar to how Innova did billions in business. Pharma companies are worldwide and serve specific markets. While the US is a big one, it's not the only one.
This and all my posts are my opinion and speculation on possible scenarios and not investment advice. Do your own due diligence.
(0)
(1)
